- Home
- DTM vs ELAN Comparison
DTM vs ELAN Comparison
Compare DTM & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DTM | ELAN |
|---|---|---|
| Founded | 2021 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 11.6B |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | DTM | ELAN |
|---|---|---|
| Price | $138.81 | $23.42 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 9 |
| Target Price | ★ $138.60 | $27.63 |
| AVG Volume (30 Days) | 789.0K | ★ 4.0M |
| Earning Date | 05-22-2026 | 05-25-2026 |
| Dividend Yield | ★ 2.53% | N/A |
| EPS Growth | ★ 19.44 | N/A |
| EPS | ★ 4.30 | N/A |
| Revenue | $1,243,000,000.00 | ★ $4,715,000,000.00 |
| Revenue This Year | $7.88 | $7.97 |
| Revenue Next Year | $7.01 | $5.21 |
| P/E Ratio | $32.44 | ★ N/A |
| Revenue Growth | ★ 26.71 | 6.22 |
| 52 Week Low | $83.30 | $8.02 |
| 52 Week High | $143.15 | $27.72 |
Technical Indicators
Market Signals| Indicator | DTM | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 63.04 | 40.22 |
| Support Level | $116.71 | $20.41 |
| Resistance Level | N/A | $23.70 |
| Average True Range (ATR) | 3.03 | 0.94 |
| MACD | -0.43 | -0.32 |
| Stochastic Oscillator | 65.03 | 11.03 |
Price Performance
Historical ComparisonAbout DTM DT Midstream Inc.
DT Midstream Inc is an owner, operator, and developer of natural gas midstream interstate and intrastate pipelines; storage and gathering systems; and compression, treatment, and surface facilities. It provides multiple, integrated natural gas services to customers through interstate pipelines, intrastate pipelines, storage systems, lateral pipelines and related treatment plants and compression and surface facilities, and gathering systems and related treatment plants and compression and surface facilities. The segments of the group are Pipeline and Gathering. It generates revenue from pipeline, storage, and gathering systems, substantially all of which are located in the Midwestern U.S., Eastern Canada, Northeastern U.S., and Gulf Coast regions.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.